Evidence map›Paper›PMID 28474623›Full record

ArticleThe Indian journal of medical research2016

Gulnaz Faritovna Korytina, Leysan Zinurovna Akhmadishina, Elena Vitalievna Viktorova, Olga Vladimirovna Kochetova, Tatyana Victorovna Viktorova

Open access · diamondAbstract read
In one paragraph

Article in The Indian journal of medical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Different Associations Between theFrontiers in genetics · 2020
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gulnaz Faritovna KorytinaDepartment of Genomics, Institute of Biochemistry & Genetics, Ufa Scientific Centre, Russian Academy of Sciences, Ufa, Russian Federation.
Leysan Zinurovna AkhmadishinaDepartment of Genomics, Institute of Biochemistry & Genetics, Ufa Scientific Centre, Russian Academy of Sciences, Ufa, Russian Federation.
Elena Vitalievna ViktorovaDepartment of Genetic Epidemiology, University Medical Center, Göttingen, Germany.
Olga Vladimirovna KochetovaDepartment of Genomics, Institute of Biochemistry & Genetics, Ufa Scientific Centre, Russian Academy of Sciences, Ufa, Russian Federation.
Tatyana Victorovna ViktorovaDepartment of Genomics, Institute of Biochemistry & Genetics, Ufa Scientific Centre, Russian Academy of Sciences; Department of Biology, Bashkortostan State Medical University, Ufa, Russian Federation.
Universitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectivesChronic obstructive pulmonary disease (COPD) is a complex chronic inflammatory disease of the respiratory system affecting primarily distal respiratory pathways and lung parenchyma. This study was aimed at investigating the association of COPD with IREB2, CHRNA5, CHRNA3, FAM13A and hedgehog interacting protein (HHIP) genes in a Tatar population from Russia.

methodsSix single nucleotide polymorphisms (SNPs) (rs13180, rs16969968, rs1051730, rs6495309, rs7671167, rs13118928) were genotyped by the real-time polymerase chain reaction in this study (511 COPD patients and 508 controls). Logistic regression was used to detect the association of SNPs and haplotypes of linked loci in different models. Linear regression analyses were performed to estimate the relationship between SNPs and lung function parameters and pack-years.

resultsThe rs13180 (IREB2), rs16969968 (CHRNA5) and rs1051730 (CHRNA3) were significantly associated with COPD in additive model [Padj =0.00001, odds ratio (OR)=0.64; Padj =0.0001, OR=1.41 and Padj =0.0001, OR=1.47]. The C-G haplotype by rs13180 and rs1051730 was a protective factor for COPD in our population (Padj =0.0005, OR=0.61). These results were confirmed only in smokers. The rs16969968 and rs1051730 were associated with decrease of forced expiratory volume in 1 sec % predicted (Padj =0.005 and Padj =0.0019). INTERPRETATION &

conclusionsOur study showed the association of rs13180, rs16969968 and rs1051730 with COPD and lung function in Tatar population from Russia. Further studies need to be done in other ethnic populations.

Indexed as

AgedCarrier ProteinsEthnicityFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGTPase-Activating ProteinsHaplotypesHumansIron Regulatory Protein 2MaleMembrane GlycoproteinsMiddle AgedNerve Tissue ProteinsPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveCarrier ProteinsCHRNA5 protein, humanFAM13A protein, humanGTPase-Activating ProteinsHHIP protein, humanIron Regulatory Protein 2Membrane GlycoproteinsNerve Tissue ProteinsReceptors, Nicotinic

Identifiers

PMID28474623
PMCPMC5433279
OpenAlexW2608834377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.